Atai Life Sciences N.v. - Net Worth and Insider Trading
Atai Life Sciences N.v. Net Worth
The estimated net worth of Atai Life Sciences N.v. is at least $42 Million dollars as of 2024-10-10. Atai Life Sciences N.v. is the 10% Owner of Compass Pathways PLC and owns about 6,905,774 shares of Compass Pathways PLC (CMPS) stock worth over $42 Million. Details can be seen in Atai Life Sciences N.v.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Atai Life Sciences N.v. has not made any transactions after 2024-09-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Atai Life Sciences N.v.
Atai Life Sciences N.v. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Atai Life Sciences N.v. owns 2 companies in total, including Intelgenx Technologies Corp (IGXT) , and Compass Pathways PLC (CMPS) .
Click here to see the complete history of Atai Life Sciences N.v.’s form 4 insider trades.
Insider Ownership Summary of Atai Life Sciences N.v.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IGXT | Intelgenx Technologies Corp | 2023-08-31 | 10 percent owner |
| CMPS | Compass Pathways PLC | 2024-09-26 | 10 percent owner |
Atai Life Sciences N.v. Latest Holdings Summary
Atai Life Sciences N.v. currently owns a total of 1 stock. Atai Life Sciences N.v. owns 6,905,774 shares of Compass Pathways PLC (CMPS) as of September 26, 2024, with a value of $42 Million.
Latest Holdings of Atai Life Sciences N.v.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CMPS | Compass Pathways PLC | 2024-09-26 | 6,905,774 | 6.03 | 41,641,817 |
Holding Weightings of Atai Life Sciences N.v.
Atai Life Sciences N.v. Form 4 Trading Tracker
According to the SEC Form 4 filings, Atai Life Sciences N.v. has made a total of 1 transactions in Compass Pathways PLC (CMPS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Compass Pathways PLC is the sale of 2,660,000 shares on September 26, 2024, which brought Atai Life Sciences N.v. around $16 Million.
Insider Trading History of Atai Life Sciences N.v.
- 1
Atai Life Sciences N.v. Trading Performance
Atai Life Sciences N.v. Ownership Network
Atai Life Sciences N.v. Owned Company Details
What does Intelgenx Technologies Corp do?
Who are the key executives at Intelgenx Technologies Corp?
Atai Life Sciences N.v. is the 10 percent owner of Intelgenx Technologies Corp. Other key executives at Intelgenx Technologies Corp include 10 percent owner Atai Life Sciences Ag , CEO Dwight Gorham , and VP & Finance&Admin - Subsidiary Karen Kalayajian .
Intelgenx Technologies Corp (IGXT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Intelgenx Technologies Corp (IGXT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intelgenx Technologies Corp (IGXT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Intelgenx Technologies Corp (IGXT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intelgenx Technologies Corp Insider Transactions
Atai Life Sciences N.v. Mailing Address
Above is the net worth, insider trading, and ownership report for Atai Life Sciences N.v.. You might contact Atai Life Sciences N.v. via mailing address: 524 Broadway, New York Ny 10013.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
